GlassScriptPhysician profile
Deborah L Ewing-Wilson
NPI 1124133483
$4,252.32
in general payments reported to CMS, 2019-2025
38 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,908 · 2020: $457 · 2021: $763 · 2022: $912 · 2023: $54.17 · 2024: $44.03 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $567.42 | 2019-2022 | |
| Abbvie INC. | $409.18 | 2021-2025 | |
| Biogen, INC. | $399.62 | 2019-2021 | |
| Ucb, INC. | $335.57 | 2019-2023 | Briviact |
| Eisai INC. | $291.89 | 2019-2022 | |
| Inspire Medical Systems, INC. | $188.42 | 2019 | |
| Amgen INC. | $165.95 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $148.73 | 2019-2022 | |
| Genzyme Corporation | $127.28 | 2019-2022 | |
| Lilly USA, LLC | $125.00 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $117.72 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $110.19 | 2022 | |
| Banner Life Sciences, LLC | $98.92 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $98.45 | 2022 | |
| Alexion Pharmaceuticals, INC. | $97.67 | 2019-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $94.79 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $87.81 | 2019-2022 | |
| Emd Serono, INC. | $84.15 | 2019-2020 | |
| Genentech USA, INC. | $71.39 | 2019-2022 | |
| Mdd US Operations, LLC | $57.54 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $57.32 | 2019-2020 | |
| Kyowa Kirin, INC. | $54.74 | 2021-2022 | |
| Lundbeck LLC | $52.30 | 2019-2020 | |
| Celgene Corporation | $45.11 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $37.78 | 2019 | |
| Acadia Pharmaceuticals INC | $37.67 | 2019 | |
| Collegium Pharmaceutical, INC. | $36.95 | 2022 | |
| Impel Pharmaceuticals INC. | $32.78 | 2022-2023 | Trudhesa |
| Harmony Biosciences LLC | $30.06 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $27.41 | 2021 | |
| Ge Healthcare | $27.24 | 2019-2021 | |
| Catalyst Pharmaceuticals, INC. | $22.38 | 2022 | |
| Aprecia Pharmaceuticals, LLC | $22.00 | 2022 | |
| Bausch Health US, LLC | $21.43 | 2019 | |
| Avanir Pharmaceuticals, INC. | $19.88 | 2019 | |
| Vertical Pharmaceuticals, LLC | $19.78 | 2019 | |
| Neurelis, INC. | $18.24 | 2021 | |
| Amneal Pharmaceuticals LLC | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Ewing-Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.